Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 173

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival

Open access
Oser, Matthew G., Fonseca, Raquel, Chakraborty, Abhishek A., Brough, Rachel, Spektor, Alexander, Jennings, Rebecca B., Flaifel, Abdallah, Novak, Jesse S., Gulati, Aditi, Buss, Elizabeth, Younger, Scott T., McBrayer, Samuel K., Cowley, Glenn S., Bonal, Dennis M., Nguyen, Quang-De, Brulle-Soumare, Laura, Taylor, Paula, Cairo, Stefano, Ryan, Colm J., Pease, Elizabeth J., Maratea, Kim, Travers, Jon, Root, David E., Signoretti, Sabina, Pellman, David, Ashton, Susan, Lord, Christopher J., Barry, Simon T., Kaelin, William G. · 2019 · Cancer Discovery

Abstract

Small cell lung cancer (SCLC) accounts for 15% of lung cancers and is almost always linked to inactivating RB1 and TP53 mutations. SCLC frequently responds, albeit briefly, to chemotherapy. The canonical function of the RB1 gene product RB1 is to repress the E2F transcription factor family. RB1 also plays both E2F-dependent and E2F-independent mitotic roles. We performed a synthetic lethal CRISPR/Cas9 screen in an RB1−/− SCLC cell line that conditionally expresses RB1 to identify dependencies that are caused by RB1 loss and discovered that RB1−/− SCLC cell lines are hyperdependent on multiple proteins linked to chromosomal segregation, including Aurora B kinase. Moreover, we show that an Aurora B kinase inhibitor is efficacious in multiple preclinical SCLC models at concentrations that are well tolerated in mice. These results suggest that RB1 loss is a predictive biomarker for sensitivity to Aurora B kinase inhibitors in SCLC and perhaps other RB1−/− cancers. Significance: SCLC is rarely associated with actionable protooncogene mutations. We did a CRISPR/Cas9-based screen that showed that RB1−/− SCLC are hyperdependent on AURKB, likely because both genes control mitotic fidelity, and confirmed that Aurora B kinase inhibitors are efficacious against RB1−/− SCLC tumors in mice at nontoxic doses. See related commentary by Dick and Li, p. 169. This article is highlighted in the In This Issue feature, p. 151

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-18-0389

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 173

Metadata

Authors
Oser, M. G., Fonseca, R., Chakraborty, A. A., Brough, R., Spektor, A., Jennings, R. B., Flaifel, A., Novak, J. S., Gulati, A., Buss, E., Younger, S. T., McBrayer, S. K., Cowley, G. S., Bonal, D. M., Nguyen, Q.-D., Brulle-Soumare, L., Taylor, P., Cairo, S., Ryan, C. J., Pease, E. J., Maratea, K., Travers, J., Root, D. E., Signoretti, S., Pellman, D., Ashton, S., Lord, C. J., Barry, S. T., & Kaelin, W. G.
Venue
Cancer Discovery
Published
2019-02-01
Volume
9
Issue
2
Pages
230-247
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W2899203698
Cited by
173
References
6
FWCI
7.49
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival. https://app.cochat.ai/papers/10.1158/2159-8290.cd-18-0389
The paper
Oser, M. G., Fonseca, R., Chakraborty, A. A., Brough, R., Spektor, A., Jennings, R. B., Flaifel, A., Novak, J. S., Gulati, A., Buss, E., Younger, S. T., McBrayer, S. K., Cowley, G. S., Bonal, D. M., Nguyen, Q.-D., Brulle-Soumare, L., Taylor, P., Cairo, S., Ryan, C. J., . . . Kaelin, W. G. (2019). Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-18-0389

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.